- Toxic Epidermal Necrolysis Induced by Sintilimab: A Case Report
-
Lye Yl, Shan B, Jia Ch, Liu J, Hou J, Du Wl, Feng R, Liang P
- KMID: 2542751
- Ann Dermatol.
- 2023 May;35(Suppl1):S100-S102.
- doi: 10.5021/ad.21.072
Sintilimab is an anti-programmed cell death receptor-1 antibody. The phase III clinical trial ORIENT-12 confirmed the safety of sintilimab combined with pemetrexed/platinum in the treatment of advanced squamous non-small cell... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk Factors Associated with Impaired Ovarian Reserve in Young Women of Reproductive Age with Crohn’s Disease
-
Zhao Y, Chen B, He Y, Zhang S, Qiu Y, Feng R, Yang H, Zeng Z, Ben-Horin , Chen M, Mao R
- KMID: 2501385
- Intest Res.
- 2020 Apr;18(2):200-209.
- doi: 10.5217/ir.2019.00103
Background/Aims: Crohn’s disease (CD) primarily affects young female adults of reproductive age. Few studies have been conducted on this population’s ovarian reserve status. The aim of study was to investigate... -
- CITED
-
- Close
- SHARE
-
- Close
- High-Pitch Coronary CT Angiography at 70 kVp Adopting a Protocol of Low Injection Speed and Low Volume of Contrast Medium
-
Feng R, Tong J, Liu X, Zhao Y, Zhang L
- KMID: 2427213
- Korean J Radiol.
- 2017 Oct;18(5):763-772.
- doi: 10.3348/kjr.2017.18.5.763
OBJECTIVE: To evaluate the feasibility and image quality (IQ) of prospectively high-pitch coronary CT angiography (CCTA) with low contrast medium injection rate at 70 kVp. MATERIALS AND METHODS: One hundred and... -
- CITED
-
- Close
- SHARE
-
- Close
- PLUNC downregulates the expression of PD-L1 by inhibiting the interaction of DDX17/β-catenin in nasopharyngeal carcinoma
-
Feng R, Guo Y, Chen M, Tian Z, Liu Y, Jiang S, Zhou J, Liu Q, Li X, Xiong W, Shi L, Fan S, Li G, Zhang W
- KMID: 2563886
- J Pathol Transl Med.
- 2025 Jan;59(1):68-83.
- doi: 10.4132/jptm.2024.11.27
Background: Nasopharyngeal carcinoma (NPC) is characterized by high programmed death-ligand 1 (PD-L1) expression and abundant infiltration of non-malignant lymphocytes, which renders patients potentially suitable candidates for immune checkpoint blockade therapies.... -
- CITED
-
- Close
- SHARE
-
- Close
